Literature DB >> 31729811

Whole-Liver Apparent Diffusion Coefficient Histogram Analysis for the Diagnosis and Staging of Liver Fibrosis.

You Zheng1,2, Yong-Sheng Xu1, Zhao Liu1, Hai-Feng Liu3, Ya-Nan Zhai1, Xiao-Rong Mao4, Jun-Qiang Lei1.   

Abstract

BACKGROUND: Conventional diffusion-weighted imaging is limited in the quantitative evaluation of liver fibrosis, and whole-liver apparent diffusion coefficient (ADC) histogram analysis might contribute to the diagnosis and staging of liver fibrosis.
PURPOSE: To explore the value of whole-liver ADC histogram parameters in the diagnosis and staging of liver fibrosis. STUDY TYPE: Retrospective. POPULATION: Twenty individuals with no liver disease and 86 patients with liver fibrosis, including 30 with chronic viral hepatitis, 29 with autoimmune hepatitis, and 27 with unexplained liver fibrosis patients. FIELD STRENGTH/SEQUENCE: 3.0T/T1 -weighted, T2 -weighted, and diffusion-weighted images. ASSESSMENT: A region of interest (ROI) was drawn in each slice of the diffusion-weighted images. Whole-liver histogram parameters were obtained with dedicated software by accumulating all ROIs. The effectiveness of the parameters in differentiating stage 1 or greater (≥F1), stage 2 or greater (≥F2), and stage 3 or greater (≥F3) liver fibrosis was assessed. STATISTICAL TESTS: Mann-Whitney U-test and receiver operating characteristic curve analysis.
RESULTS: Kurtosis, entropy, skewness, mode, and 90th and 75th percentiles exhibited significant differences among the pathological fibrosis stages (P < 0.05). Kurtosis was found to be the most meaningful parameter in differentiating fibrosis stages of the viral hepatitis, autoimmune hepatitis, and unexplained liver fibrosis group (area under the curve) (AUC = 0.793, 0.771, 0.798, respectively). In the combined liver fibrosis group, kurtosis achieved the highest AUC (0.801; 95% confidence interval [CI]: 0.702-0.900; sensitivity: 0.750; specificity: 0.850; positive likelihood ratio: 4.953; negative likelihood ratio: 0.302; positive predictive value: 0.946; negative predictive value: 0.486), with a cutoff value of 1.817, in differentiating fibrosis stage ≥F1. DATA
CONCLUSION: Kurtosis, entropy, skewness, mode, and 90th and 75th percentiles may contribute to the diagnosis and staging of liver fibrosis, especially kurtosis. LEVEL OF EVIDENCE: 4 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2020;51:1745-1754.
© 2019 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  apparent diffusion coefficient; histogram; liver fibrosis; magnetic resonance imaging

Mesh:

Year:  2019        PMID: 31729811     DOI: 10.1002/jmri.26987

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  6 in total

1.  A novel radiomics signature based on T2-weighted imaging accurately predicts hepatic inflammation in individuals with biopsy-proven nonalcoholic fatty liver disease: a derivation and independent validation study.

Authors:  Zhong-Wei Chen; Huan-Ming Xiao; Xinjian Ye; Kun Liu; Rafael S Rios; Kenneth I Zheng; Yi Jin; Giovanni Targher; Christopher D Byrne; Junping Shi; Zhihan Yan; Xiao-Ling Chi; Ming-Hua Zheng
Journal:  Hepatobiliary Surg Nutr       Date:  2022-04       Impact factor: 7.293

2.  Alterations to cognitive abilities and functional networks in rats post broad-band intense noise exposure.

Authors:  Xiao-Min Xu; Yu-Qun Zhang; Feng-Chao Zang; Chun-Qiang Lu; Li-Jie Liu; Jian Wang; Richard Salvi; Yu-Chen Chen; Gao-Jun Teng
Journal:  Brain Imaging Behav       Date:  2022-05-11       Impact factor: 3.224

3.  The value of multiparametric histogram features based on intravoxel incoherent motion diffusion-weighted imaging (IVIM-DWI) for the differential diagnosis of liver lesions.

Authors:  Zhu Ai; Qijia Han; Zhiwei Huang; Jiayan Wu; Zhiming Xiang
Journal:  Ann Transl Med       Date:  2020-09

4.  Assessment of renal function using magnetic resonance quantitative histogram analysis based on spatial labeling with multiple inversion pulses.

Authors:  Ping Liang; Shichao Li; Chuou Xu; Jiali Li; Fangqin Tan; Daoyu Hu; Ihab Kamel; Zhen Li
Journal:  Ann Transl Med       Date:  2021-11

Review 5.  Therapeutic and diagnostic targeting of fibrosis in metabolic, proliferative and viral disorders.

Authors:  Alexandros Marios Sofias; Federica De Lorenzi; Quim Peña; Armin Azadkhah Shalmani; Mihael Vucur; Jiong-Wei Wang; Fabian Kiessling; Yang Shi; Lorena Consolino; Gert Storm; Twan Lammers
Journal:  Adv Drug Deliv Rev       Date:  2021-06-15       Impact factor: 15.470

Review 6.  Multiparametric MR mapping in clinical decision-making for diffuse liver disease.

Authors:  Helena B Thomaides-Brears; Rita Lepe; Rajarshi Banerjee; Carlos Duncker
Journal:  Abdom Radiol (NY)       Date:  2020-08-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.